Does RANOLAZINE Cause Coronary arterial stent insertion? 95 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 95 reports of Coronary arterial stent insertion have been filed in association with RANOLAZINE (Ranolazine). This represents 1.0% of all adverse event reports for RANOLAZINE.
95
Reports of Coronary arterial stent insertion with RANOLAZINE
1.0%
of all RANOLAZINE reports
0
Deaths
49
Hospitalizations
How Dangerous Is Coronary arterial stent insertion From RANOLAZINE?
Of the 95 reports, 49 (51.6%) required hospitalization.
Is Coronary arterial stent insertion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RANOLAZINE. However, 95 reports have been filed with the FAERS database.
What Other Side Effects Does RANOLAZINE Cause?
Death (692)
Myocardial infarction (610)
Stent placement (593)
Chest pain (592)
Angina pectoris (583)
Dizziness (517)
Dyspnoea (348)
Cerebrovascular accident (334)
Fall (299)
Off label use (270)
What Other Drugs Cause Coronary arterial stent insertion?
ROSIGLITAZONE (1,698)
METFORMIN\ROSIGLITAZONE (245)
ADALIMUMAB (175)
EVOLOCUMAB (109)
RISANKIZUMAB-RZAA (94)
AVANDIA (68)
ETANERCEPT (67)
IBRUTINIB (54)
UPADACITINIB (52)
FLUTICASONE\SALMETEROL (45)
Which RANOLAZINE Alternatives Have Lower Coronary arterial stent insertion Risk?
RANOLAZINE vs RAPAMUNE
RANOLAZINE vs RASAGILINE
RANOLAZINE vs RASBURICASE
RANOLAZINE vs RAVULIZUMAB
RANOLAZINE vs RAVULIZUMAB-CWVZ